Amira Medical Announces Hiring of Andrew Galligan and Nina Peled.SCOTTS VALLEY, Calif.--(BW HealthWire)--Nov. 16, 1998--Andrew Galligan has joined Amira Medical as vice president/finance and chief financial officer, and Nina Peled, Ph.D. has joined the company as vice president/Scientific Affairs. Amira Medical is a leader in the development of blood glucose monitoring blood glucose monitoring Sugar monitoring Lab medicine The periodic testing of serum glucose in Pts known to have DM. See Bedside glucose monitoring, Beta cell implants, Diabetes, Glucometer, Glycosylated hemoglobin, Non-Invasive glucose monitoring. methods that cause less pain for people with diabetes. The company's AtLast Blood Glucose Monitoring System has been submitted to the Food and Drug Administration for market clearance. "We are thrilled to have Andrew Galligan and Nina Peled join our team," said Karen Drexler, chief executive officer and a founder of Amira Medical. "Andrew is well known and respected among investors and in the high-technology business and finance community, while Nina has extensive diabetes industry knowledge with a proven record in product launches." Prior to joining Amira Medical, Galligan was vice president finance and chief financial officer of Molecular Devices Molecular Devices Corporation is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. Corp. of Sunnyvale, Calif. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :MDCC MDCC Miami Dade Community College MDCC Mississippi Delta Community College MDCC Maintenance Data Collection Center MDCC Mobile Data Capture and Communications ), an analytical instrumentation company in the life sciences market. He was a key member of the management team directing Molecular Devices' strong growth and successful initial public offering. Earlier in his career Galligan held vice president positions at IPS Health Care Inc., Lumisys Inc. and Diasonics Corp. Dr. Peled had a long tenure with Boehringer Mannheim Corp., where she worked on the launch and product support of various blood glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence monitors. Subsequently, she held various senior regulatory, clinical and scientific positions with I-STAT Corp. and most recently was vice president of Regulatory Affairs Regulatory Affairs (RA), also called Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. Regulatory Affairs professionals usually have responsibility for the following general areas: abbr. Master of Business Administration Noun 1. MBA - a master's degree in business Master in Business, Master in Business Administration and a Ph.D. in physical chemistry. When cleared for marketing, Amira Medical's blood sampling approach will eliminate painful fingersticks, allowing people with diabetes to sample their blood at the site that is most comfortable and convenient for them. The company's blood sampling technology was recently featured at meetings of the American Diabetes Association The American Diabetes Association, or the ADA, is an American health organization providing diabetes research, information and advocacy. Founded in 1940, the American Diabetes Association conducts programs in all 50 states and the District of Columbia, reaching hundreds of and the American Association of Diabetes Educators. Founded in 1996, Amira Medical is a customer oriented company whose potential products offer technological innovation in home blood glucose monitoring. Amira's mission is to create solutions to diabetes management that reduce pain and are accurate, simple and convenient, utilizing basic technologies in a creative, cost-effective way. These solutions will provide significant benefits to individuals with diabetes and the healthcare professionals who treat them. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion